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Abstrak 
Background: Oligonol
®
 (OLG) is raw materials for functional foods or cosmetics 
which contains low-molecular-weight polyphenols derived from lychee fruit 
(Litchi chinensis Sonn.). It has been reported to many functions such as anti-
inflammatory and anti-oxidants. 
Aim: In this study, with the aim of exploring new functionalities of OLG on the 
scalp and hair growth, we investigate i ts effect on human dermal papilla cells 
(HDPC) by comparing it with adenosine and minoxidil at the genetic level. 
Method: OLG, adenosine, and minoxidil were applied to HDPC culture lines for 
24 h, after which VEGF, FGF-7, WNT5a, and WNT10a mRNA expression was 
measured by real-time PCR analysis. Additionally, using DNA microarrays, we 
investigated their effects on 205 inflammation-related genes.  
Result: The FGF-7, and WNT10a mRNA expression were observed in HDPC 
added with OLG. The results of the DNA microarray analysis showed that the 
expression of 11 genes was suppressed by OLG. These functions of OLG on 
HDPC were not the same as adenosine and minoxidil.  
Conclusions: OLG may affect the function of HDPC by regulating the expression 
of genes related to cell proliferation and inflammation. 
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INTRODUCTION 
Various treatments for hair growth are currently 
being developed. Finasteride, dutasteride, and 
minoxidil are representative hair loss treatment 
medicines used as pharmaceutical ingredients in 
Japan. 
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 Finasteride has been applied to treat male 
androgenic alopecia (AGA) as a substance inhibiting 
the conversion of the male hormone testosterone to 
dihydrotestosterone by 5α-reductase.Dutasteride was 
also developed as a substance having higher 5α-
reductase inhibitory activity than finasteride.
1,2
 
 Minoxidil was originally developed as an 
antihypertensive drug. However, it was confirmed to 
have a side effect of promoting hair growth, so the 
developmental target was changed to a hair growth 
agent. Subsequent studies have reported that it 
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promotes the production of vascular endothelial 
growth factor (VEGF) at the cellular level.
3 
 In the search for ingredients with an effect of 
promoting hair growth, attention has been drawn to 
natural substances. For example, Cotsarelis et al.
4
 
reported that cultured HDPC of the thin hair portion 
and non-thin hair portion from subject exhibiting 
male pattern epilation (AGA) and then analyzed gene 
expression of the HDPC by DNA microarray.The 
results showed that the gene expression level of 
fibroblast growth factor 7 (FGF-7) was greatly 
decreased in HDPC of the thin hair portion.
5
 
 Based on this research, a screening of components 
promoting the expression of the FGF-7 gene in HDPC 
was carried out, and adenosine became a candidate 
substance. Adenosine is currently approved as a 
quasi-drug component by the Japanese Ministry of 
Health, Labor and Welfare, and is marketed as an 
external preparation for hair growth. 
 Thus, a screening system for examining the gene 
expression of HDPC is useful, and various genes such 
as VEGF, FGF, hepatocyte growth factor (HGF), 
insulin-like growth factor (IGF), and WNT are now 
attracting attention as target genes for hair growth 
function.
6,7
Regardingnatural substances other than 
adenosine that could be used, polyphenol procyanidin 
B2 from apple fruits has been reported to affect hair 
growth in a murine experiment and a human clinical 
trial.
8,9 
However, the mechanism has not been fully 
clarified. 
 Meanwhile, we have developed raw materials for 
functional foods or cosmetics which industrially low-
molecular-weight polyphenols (Oligonol; OLG) 
derived from lychee fruit (Litchi chinensis Sonn.).The 
polyphenols in OLG are oligomerized through a 
novel manufacturing process. It is made by 
technological oligomerization of polyphenol 
polymers in the extract and contains a relatively high 
proportion of catechin-type monomers and oligomers 
of proanthocyanidin. It has been reported that 
polyphenols such as epicate chin gallate (ECG), 
epigallo cate chin gallate (EGCG), and procyanidins 
A1, A2, B1, and B2 are contained in this OLG.
10,11
 
Previous studies showed that OLG is safe and that it 
has anti-oxidant capacity and relatively high 
bioavailability.Regarding other functional studies of 
OLG,anti-inflammatory, anti-diabetic, and anti-
metabolic syndrome effects in vitro, in vivo, and in 
clinical trials has been reported.
 12,13,14,15
 
 Against this background, we focused on the effect 
of promoting hair growth as a new functional search 
for OLG rich in polyphenols. As described above, 
several screening methods related to an effect of 
promoting hair growth has been developed. In this 
study, we first performed in vitro experiments using 
HDPC. Specifically, we carried out gene expression 
analysis on HDPC by real-time PCR, and then 
investigated other gene fluctuations by DNA 
microarray. And we discussed the possibility that 
OLG could be used as a substance promoting hair 
growth. 
 
 
MATERIALSAND METHODS  
Reagents and sample preparation 
 Oligonol
®
 powder(OLG, lot OLG-F1502S) was 
supplied by Amino Up Chemical Co. Ltd. (Sapporo, 
Japan) and dissolved in dimethyl sulfoxide (DMSO; 
Nacalai Tesque Inc., Kyoto, Japan) to prepare a 500 
mg/mL stock solution. Minoxidil was obtained from 
Sigma-Aldrich Japan (Tokyo, Japan) was dissolved in 
50% ethanol to prepare a 15 mM (4.3mg/mL) stock 
solution. Adenosine was obtained from Wako Inc. 
(Tokyo, Japan) was dissolved in DMSO to prepare a 
100 mM (26.7mg/mL) stock solution. These stock 
solutions were used for addition to cell culture. These 
minoxidil and adenosine were used as positive 
controls.  
 Dermal follicle papilla cell growth media (Toyobo 
Inc., Osaka, Japan), dermal follicle papilla cell 
subculturing unit (Toyobo Inc.), Ninety-six-well and 
Forty-eight-well Cell matrix Type I-C (Nitta-gelatin 
Inc., Osaka, Japan) culture plates, and live cell count 
reagent SF (Nacalai Tesque Inc., Kyoto, Japan) were 
purchased. 
 Fast Lane Cell® cDNA Kit ( Qiagen Co., Ltd., 
Venlo, the Netherlands), 5 mL of SYBR
®
 Premix Ex 
Taq(Takara Inc., Shiga, Japan), and oligonucleotides 
(primers) (FASMAC Inc., Kanagawa, Japan) were 
purchased for use in quantitative real-time PCR 
(qPCR) (Table 1). Message Amp II biotin-enhanced 
amplification kit and fragmentation reagents were 
pure chased from Applied Bio systems Japan (Tokyo, 
Japan). 
 All other laboratory chemicals were of the highest 
purity from commercial suppliers. 
 
Table 1.  Summary of primer sequences used for 
HDPC in qPCR analysis.  
 
Gene Primer name Sequence (5’- 3’) 
FGF-7 FGF7-For1 tctgtcgaacacagtggtacctgag 
 FGF7-Rev1 gccactgtcctgatttccatga 
VEGF VEGFA-For2 aaagcatttgtttgtacaagatccg 
 VEGFA-Rev2 cttgtcacatctgcaagtacgttcg 
WNT5a WNT5A-For3 caagttggtacaggtcaacagccgc 
 WNT5A-Rev3 gagccggtgctctcattgcgcacgc 
WNT10a WNT10A-For4 ggtcccggaacacccagccctgccc 
 WNT10A-Rev4 ttagaaaagcgctccccgaagccc 
GAPDH GAPDH-RT-For1 catccctgcctctactggcgctgcc 
 GAPDH-RT-Rev ccaggatgcccttgagggggccctc 
 
Cell viability test  
 HDPC were obtained from the skullcap of a 63-
year-old Caucasian male (Code No. CA602t05a; 
Toyobo Inc.). HDPC (5,000 cells / well) were plated 
on cell culture plate (96 wells, 6 mm diameter) with 
the culture medium and incubated at 37 ℃ in 5 % 
CO2 / 95% air for 24h. The culture supernatant were 
substituted for the culture medium including OLG 
(0.032-100µg/mL, triplicate) and cultured at 37 ℃ in 
5 % CO2 / 95% air for 24h. The cell viability of the 
cultures was determined by cell count reagent SF, 
modified method in MTT assay. Briefly, the culture 
supernatant were replaced by a conditioned medium 
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including SF (10 % WST-8,Tetrazolium Salts) 
reagent and incubated at 37 ℃ in 5 % CO2 / 95% air 
for 2h. The absorbance was measured at 450 nm by 
microplate reader. The cell viabilities were compared 
with vehicle (0.1% DMSO).   
 
Cell culture and cDNA preparation 
 For the gene expression tests regarding qPCR and 
DNA microarray, a control (medium, duplicate), 
vehicle (0.1% DMSO, duplicate), adenosine (final 
concentration of 100μM, duplicate), minoxidil (final 
concentration of 30μM, duplicate), and OLG (final 
concentrations of 4, 20, and 100µg/mL, 
duplicate)were added to cell culture plates and 
incubated for 24h.  
 Fast Lane Cell
®
 cDNA Kit was used to extract 
total RNA, and 2 µL of gDNA Wipeout Buffer, 1µl 
of Fast Lane Lysate, and 1µL of RNase-free water 
were added to a PCR tube, and incubated at 42°C for 
5 min. Then, 6µL of reverse transcription master mix 
solution (1 µL of Quantiscript Reverse Transcriptase, 
4 µL of Quantiscript RT Buffer, 1 µL of RT Primer 
Mix) was added and incubated at 42°C for 30 min. 
Finally, the mixture was incubated at 95°C for 3 min 
to inactivate the reverse transcriptase, and the product 
was used as synthesized cDNA for the quantitative 
real-time polymerase chain reaction (qPCR) and 
DNA microarray analysis.  
 
Quantitative real-time polymerase chain reaction 
 qPCR was performed using SYBR® Premix Ex 
Taq. Previously reported primers were used. PCR 
conditions were set at 95°C for 10 s and 60°C for 30 
s. Relative quantification was performed by 
normalizing target expression to the housekeeping 
gene GADPH. Data are expressed as change in FGF-
7, VEGF, WNT5a, and WNT10a mRNA expression 
compared with that in HDPC incubated without 
samples (control). 
 
DNA microarray Human-allergy Chip
®
 
 cDNA was prepared from the RNA, and biotin-
labeled RNA was transcribed and amplified using a 
Message Amp II biotin-enhanced amplification kit, in 
accordance with the manufacturer’s instructions. 
Biotinylated amplified RNA (aRNA) was fragmented 
using fragmentation reagents and then incubated at 
94°C for 7.5 min. The fragmentation reaction was 
terminated by the addition of stop solution. 
Hybridization was carried out with a DNA microarray 
(Genopal
®
; Mitsubishi Rayon Co., Yokohama, 
Japan). The special chip used for the DNA microarray 
was the Human-allergy Chip
®
 (equipped with 205 
types of genes on the surface of chip).Hybridization 
signal acquisition was performed using a DNA 
microarray reader adopting multi beam excitation 
technology (Yokogawa Electric Co., Tokyo, Japan). 
These experimental flows are shown in Figure1. 
 
 
 
 
 
 
 
 
 
Figure 1.  Experimental flow for cell viability test 
and genes expression analysis on HDPC cultured with 
samples. 
 
Statistical analysis 
 Results are expressed as means ± standard error of 
the mean (S.E). Statistical significance was performed 
using EXCEL 2015 ver.1.15software. The Dunnett’s 
multiple comparison test was used to compare 
relative gene expression levels and cell viability. A p-
value of < 0.05was considered statistically significant. 
In the DNA microarray analysis, a 2.0-fold change in 
expression or suppression, as measured by the signal 
intensity ratio (SIR, log2 [Sample Signal 
intensity/Control Signal intensity]), was interpreted as 
differential expression. Level of SIR (+1 or more, -1 
or less; 2.0-fold change) is defined as differential 
expression genes (DEGs).  
 
RESULTS 
Cell viability test: The results of OLG on the 
viability of HDPC revealed safety of cytotoxicity, 
even when a maximum concentration of 100µg/mL 
was used (Figure2). Therefore, 4, 20, and 100 µg/mL 
OLG were used in the qPCR and DNA microarray 
analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Measurement of viability of HDPC 
cultured with OLG.  The HDPC were cultured with 
OLG (0.032-500 µg/mL, triplicate) for 24 h. 
Significant differences (**P < 0.01) were obtained 
between the group of OLG and control. Vehicle = 
0.1% DMSO. 
 
Quantitative real-time polymerase chain reaction:  
 Figure 3 shows the results from the analysis of 
FGF-7, VEGF, WINT5a, and WINT10a mRNA 
expression. For FGF-7 mRNA, significant expression 
(P < 0.01) was observed after adenosine addition; 
similarly, significant expression (*P < 0.05) was 
confirmed upon OLG (100 µg/mL) treatment (A).For 
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VEGF, no significant mRNA expression was 
confirmed upon minoxidil or OLG treatment (B).For 
WNT5a mRNA, no significant expression was 
observed after the addition of each of samples (C); on 
the other hand, significant WNT10a mRNA 
expression was confirmed with adenosine (*P < 0.05) 
and OLG(100 µg/mL) (**P < 0.01)treatment (D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The mRNA expression of FGF-7, VEGF, 
WNT5a, and WNT10a in HDPC treated with each of 
samples. The mRNA expression levels in HDPC 
cultured with adenosine (100 µM), minoxidil (30 
µM), and OLG (4, 20, and 100 µg/mL). The FGF-7 
(A), VEGF (B), WNT5a (C), and WNT10a (D) 
mRNA levels measured qPCR. Significant 
differences (*P < 0.05, **P < 0.01) were obtained 
between the group of samples and control .vehicle = 
0.1% DMSO. 
 
DNA microarray Human-allergy Chip
®
. 
The results of the Human-allergy Chip
®
 analysis 
showed that 74 of 205 genes were suppressed and 4 
of 205 genes were expressed in the adenosine 
treatment. In the minoxidil treatment, 74 of 205 genes 
were suppressed, while in the OLG treatment 11 of 
205 genes were suppressed (Figure4).Among these 
DEGs, 53 of 74 genes were found to be commonly 
inhibited by adenosine and minoxidil. One gene (1 of 
11) for which the expression was suppressed by both 
OLG and minoxidil was interleukin 8 (IL-8) 
(Figure5). 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Number of DEGs (up regulated and down 
regulated genes) in HDPC treatment with adenosine 
(n=1), mioxidil (n=1), and OLG(n=1), as analyzed by 
DNA microarrays 
 
 
 
 
 
 
 
 
 
Figure 5. Venn diagram of DEGs from DNA 
microarray on each samples treatments HDPC.  The 
number in each area shows the number of DEGs. This 
venn diagram summarizes the overlap of DEGs from 
the left circle (AD vs. MX) and the right circle (MX 
vs. OLG). Fifty-three DEGs were shared between AD 
and MX, while only one was shared between DEG 
and MX. AD; adenosine, MX; minoxidil 
 
 Additionally, 4 of 205 genes expressed as DEGs 
in the adenosine treatment were confirmed,as follows: 
nuclear factor of activated T cells, cytoplasmic, 
calcineurin-dependent 1, transcript variant 2 
(NFATC1), tumor necrosis factor receptor super 
family, member 4 (TNFRSF4/OX40), CD82 
molecule, transcript variant 1 (CD82/Kai1), and 
signal transducer and activator of transcription 4 
(STAT4). 
 Moreover, 11 of 205 genes suppressed in the OLG 
(100 μg/mL) treatment were confirmed: interleukin 1 
beta (IL-1β), interleukin 6(IL-6), interleukin 8 (IL-8), 
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interleukin 11 (IL-11),interleukin 18 receptor 1 
(IL18r1), Jun B proto-oncogene (JUNB), FOS-like 1 
(FOSL1), intercellular adhesion molecule 1 (ICAM1), 
leukocyte-associated Ig-like receptor 1 
(LAIr1),prostaglandin-endoperoxide synthase 2 
(PTGS2), and TNF receptor-associated factor 1 
(TRAF1) mRNA (Table 2). 
 
Table 2. List of DEGs due to OLG treatment using DNA 
microarrays (Human-allergy Chip)in HDPC. 
 
Gene symbol Gene name SIR 
IL-1β 
Homo sapiens interleukin 1, beta 
(IL1B), mRNA 
-1.48 
IL-6 
Homo sapiens interleukin 6 (interferon, 
beta 2) (IL6), mRNA 
-2.07 
IL-8 
Homo sapiens interleukin 8 (IL8), 
mRNA 
-3.15 
IL11 
Homo sapiens interleukin 11 (IL11), 
mRNA 
-2.07 
IL18r1 
Homo sapiens interleukin 18 receptor 1 
(IL18R1), mRNA 
-2.12 
JUNB 
Homo sapiens jun B proto-oncogene 
(JUNB), mRNA 
-2.02 
FOSL1 
Homo sapiens FOS-like antigen 1 
(FOSL1), mRNA 
-1.08 
ICAM1 Homo sapiens intercellular adhesion 
molecule 1 (CD54), 
human rhinovirus receptor (ICAM1), 
mRNA 
-1.27 
LAIr1 Homo sapiens leukocyte-associated 
immunoglobulin-like receptor 1 
(LAIR1), transcript variant a, mRNA 
-1.19 
PTGS2 Homo sapiens prostaglandin-
endoperoxide synthase 2 (prostaglandin 
G/H synthase and cyclooxygenase) 
(PTGS2), mRNA 
-1.04 
TRAF1 Homo sapiens TNF receptor-associated 
factor 1 (TRAF1), mRNA 
-1.01 
 
DISCUSSION 
 In the present study, we investigated the influence 
of OLG on HDPC collected from the scalps of 
healthy donors with hair loss, as primary screening 
for the effect of OLG on hair growth. First, we used 
qPCR to investigate the expression of VEGF, FGF-7, 
WNT5a, and WNT10amRNA in HDPC. 
 Adenosine and minoxidil are reported to affect 
hair growth, as well as the expression of FGF-7 and 
VEGF mRNA, which has been a recent focus in this 
field. Therefore, we also used adenosine and 
minoxidil as positive controls in this gene expression 
experiment. It has been reported that the WNT gene 
induces downstream activation (of the β-catenin 
gene), which promotes hair follicle 
formation.
16
Therefore, the VEGF, FGF-7, WNT 5a, 
and WNT 10a genes have attracted attention as target 
genes of hair growth activity and were focused on in 
an in vitro experiment. 
 VEGF promotes vascularization of the hair-bulb 
region and improves circulation to the hair. This is 
believed to increase the flow of necessary nutrients to 
the hair and thus promotes hairgrowth.
17,18 
However, 
the results showed that the difference was not found 
to be significant. The lack of a significant difference 
for minoxidil is likely to be associated with the 
culture conditions or individual differences of the 
donors of the HDPC. 
 In contrast, the expression of FGF-7 mRNA was 
found to be significantly promoted by adenosine and 
OLG treatments. FGF-7 was reported to promote hair 
growth by accelerating cell proliferation, such as both 
hair matrix and hair root sheath cells from dermal 
papilla cells. Adenosine has also been reported to 
facilitate FGF-7 production via the adenosine A2b 
receptor in dermal papilla cells. Immuno histo 
chemical staining confirmed that the adenosine A2b 
receptor protein was expressed in the surrounding 
HDPC and outer root sheath in the hair follicles of 
healthy humans.
5 
 Additionally, OLG significantly promoted the 
expression of WNT10a mRNA. This WNT signal is 
related to cellular proliferation and differentiation and 
is well known in the context of protein networks 
related to embryogenesis and cancer, particularly with 
respect to the β-catenin pathway, which suppresses 
gene expression through β-catenin. Consequently, 
recent research has raised expectations that the 
expression of the WNT gene in HDPCwould promote 
hair growth by participating in cellular proliferation.
19 
These results suggested that OLG induces the mRNA 
of FGF-7 and WNT 10a of HDPC to exhibit hair 
growth activity. 
 Normal DNA microarrays allow comprehensive 
analysis of the expression of more than 20,000 genes; 
however, by using the DNA microarray (Genopal
®
) 
used in the present study, which is refined to gene 
probes for around 200 genes in each experiment, it is 
possible to conduct genetic analyses more 
economically and easily. The chip used in the present 
study was the Human-allergy Chip
®
 (equipped with 
205 types of genes associated with 
inflammation).
20
The results showed that 11of 205 
DEGs were suppressed by the OLG (100 μg/mL) 
treatment, namely, IL-1β, IL-6, IL-8, IL-11, IL18r1, 
JUNB, FOSL1, ICAM1, LAIr1, PTGS2,and TRAF1. 
 From these data, it is difficult to consider the 
meaning of the suppression of these genes, but it is 
interesting that the genes suppressed by minoxidil and 
adenosine are different from those suppressed by 
OLG. In addition, since the number of genes 
suppressed by minoxidil and adenosine is greater than 
the number of genes suppressed by OLG, minoxidil 
and adenosine may have stronger anti-inflammatory 
effects than OLG. Regarding the association between 
hair growth and anti-inflammatory effects, it has been 
reported that the suppression of inflammation 
improves the condition of the scalp, and suppresses 
apoptosis in HDPC.
21,22.
 
 
CONCLUSIONS 
 These results finds that OLG promotes the 
expression of the mRNA of FGF-7 and WNT10a and 
inhibits several genes related to inflammation, so 
further research on hair growth-promoting substances 
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exhibiting different mechanisms from minoxidil and 
adenosine is expected. 
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